Gene · 4240
NIH grants1,863
NIH grants whose papers are about the gene, through NIH's grant-paper links.
1 to 20 of 1,863
Download this page as JSON| Grant | Title | MFGE8 papers | Newest fiscal year |
|---|---|---|---|
| ZIAAG000237 | Age-Associated Changes in Arterial Proteome and Aortic Smooth Muscle Signaling | 10 | 2025 |
| ZIAAG000240 | Progression of Arterial Aging: the Local MCP-1/MMP-2/TGF-beta 1 Signaling Loop | 9 | 2025 |
| R35GM118337 | Novel Approaches to Maintaining Organ Function in Sepsis | 7 | 2025 |
| ZIAAG000236 | Calpain-1 Activity and Central Arterial Aging | 6 | 2025 |
| ZIAAG000239 | Effect of Metalloprotease Inhibition on Age-Associated Arterial Remodeling | 6 | 2025 |
| P30EY007003 | University of Michigan Vision Research Center | 5 | 2025 |
| R01HL076179 | Improvement of Organ Function after Severe Hypovolemia | 5 | 2025 |
| P20GM103449 | Vermont Biomedical Research Network-Vermont INBRE | 4 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 4 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 4 | 2025 |
| P01AG026276 | Antecedent Biomarkers for Alzheimer Disease: The Adult Children Study | 3 | 2025 |
| P20GM121342 | SC COBRE for TranslationalResearch Improving MusculoskeletalHealth (SC-TRIMH) | 3 | 2025 |
| P30CA044579 | University of Virginia Cancer Center Support Grant | 3 | 2025 |
| P30DK116074 | Stanford Diabetes Research Center | 3 | 2025 |
| P30EY014801 | Miami Center for Vision Research | 3 | 2025 |
| R01AG079234 | Heterotypic amyloid interactions as modulators of selective cellular vulnerability | 3 | 2025 |
| R01DK064380 | Molecular Mechanisms Regulating Epithelial Cell Apical Polarity and Ciliogenesis | 3 | 2025 |
| R28AA012725 | Brain Tissue Resource Center for Alcohol Research | 3 | 2025 |
| R35GM145409 | Inhibition of Human Islet Amyloid Polypeptide Aggregation | 3 | 2025 |
| R37DE026152 | Local endogenous regulators of functional immune plasticity in the periodontium | 3 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4240/grants